We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Highlights Severe Skin Reactions With Revlimid
FDA Highlights Severe Skin Reactions With Revlimid
September 19, 2008
The FDA is cautioning physicians that Celgene’s multiple myeloma treatment Revlimid might be associated with the serious skin reactions Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).